Måndag 10 Augusti | 13:39:20 Europe / Stockholm
Est. tid*
2027-02-26 08:00 Bokslutskommuniké 2026
2026-10-20 08:00 Kvartalsrapport 2026-Q3
2026-07-21 - Kvartalsrapport 2026-Q2
2026-06-26 - Årsstämma
2026-05-08 - X-dag ordinarie utdelning PTRK 0.00 SEK
2026-04-23 - Kvartalsrapport 2026-Q1
2026-02-27 - Bokslutskommuniké 2025
2025-10-21 - Kvartalsrapport 2025-Q3
2025-07-24 - Kvartalsrapport 2025-Q2
2025-06-30 - X-dag ordinarie utdelning PTRK 0.00 SEK
2025-06-27 - Årsstämma
2025-05-13 - Kvartalsrapport 2025-Q1
2025-02-28 - Bokslutskommuniké 2024
2024-11-12 - Kvartalsrapport 2024-Q3
2024-08-13 - Kvartalsrapport 2024-Q2
2024-05-14 - Kvartalsrapport 2024-Q1
2024-05-06 - X-dag ordinarie utdelning PTRK 0.00 SEK
2024-05-03 - Årsstämma
2024-02-29 - Bokslutskommuniké 2023
2023-11-14 - Kvartalsrapport 2023-Q3
2023-08-15 - Kvartalsrapport 2023-Q2
2023-05-04 - X-dag ordinarie utdelning PTRK 0.00 SEK
2023-05-03 - Årsstämma
2023-05-02 - Kvartalsrapport 2023-Q1
2023-02-28 - Bokslutskommuniké 2022
2022-11-07 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-26 - Kvartalsrapport 2022-Q1
2022-05-04 - X-dag ordinarie utdelning PTRK 0.00 SEK
2022-05-03 - Årsstämma
2022-02-24 - Bokslutskommuniké 2021
2021-10-20 - Kvartalsrapport 2021-Q3
2021-07-28 - Kvartalsrapport 2021-Q2
LandStorbritannien
ListaFirst North Stockholm
SektorInformationsteknik
IndustriProgramvara
Physitrack är verksamt inom hälsovårdssektorn och specialiserat inom sjukgymnastik. Produktportföljen inkluderar digitala vårderbjudanden till företag via SaaS-lösningar. Utöver huvudverksamheten erbjuds även personlig service och tillhörande kringtjänster. Verksamheten drivs globalt med störst närvaro inom Europa och Nordamerika. Physitrack grundades år 2012 och har sitt huvudkontor i London.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Physitrack commences share buyback program

2026-08-10 10:45:00

Physitrack PLC (Nasdaq First North Premier Growth Market: PTRK) today announces that it has commenced its previously announced share buyback program.

London, 10 August 2026

The purpose of the share buyback program is to optimise the Company’s capital structure and create additional value for shareholders.

The share buyback program is being carried out pursuant to the authorisation granted by the Annual General Meeting on 26th May 2026 and the subsequent resolution by the Board of Directors on 16th July 2026.

Under the program, Physitrack may repurchase up to 1,626,077 ordinary shares for a maximum aggregate consideration of EUR 120,000. The program commenced on 10 August 2026 and will continue until further notice, unless the maximum number of shares or maximum aggregate consideration is reached earlier.

Physitrack has appointed Pareto Securities AB to execute the share repurchases on behalf of the Company. Pareto Securities will make its trading decisions independently of, and without influence from, Physitrack.

The share repurchases will be carried out on Nasdaq Stockholm in accordance with applicable rules and regulations and within the parameters of the programme and the authorisation granted by the Annual General Meeting.

Transactions under the program will be reported to Nasdaq Stockholm on a daily basis in accordance with applicable requirements.

In addition, Physitrack will publish a press release each Monday during the program, providing details of the shares repurchased during the preceding week, including the total number of shares acquired and the volume-weighted average purchase price.